Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07435519

Effects of Klapp Method in Upper Cross Syndrome Patients

This study was conducted to determine the effects of Klapp Method on posture, craniovertebral angle and disability in upper cross syndrome patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Upper Cross Syndrome Oculocerebral hypopigmentation syndrome type Preus

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fazle Omar Hospital

Rabwah, Punjab Province, 35460, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Both genders were included
  • Participants were between the ages of 18 to 40.
  • The craniovertebral angle was less than or equal to 50 degrees
  • The REEDCO Posture Assessment Scale of 59% or less.

Exclusion criteria

  • Patients that had a history of vascular syndrome, cervical spine infection, trauma, surgery, or cervical spine damage
  • Patients with inflammatory arthritis (such as rheumatoid arthritis or ankylosing spondylitis)

Treatment and study plan

Klapp Method

Other

Klapp Method: 3 sessions/week for 6 weeks Four-point walk followed by two-point walk & back walk Breathing exercise from a kneeling position Simple bounce glide with simultaneous breathing Bunny hop

Breathing exercise from a quadrupedal position:

Greetings

conventional treatment

Other

Conventional Physical Therapy Treatment : 3 sessions/week for 6 weeks Hot pack 10 min Stretching exercises for Levator scapulae 3 sets for 30 sec hold each. Upper trapezius 3 sets for 30 sec hold each. Pectoralis stretches: 3 sets for 30 sec hold each.

Strengthening was given to :

Upper, Middle and Lower Trapezius: 10 repetitions 3 sets. Serratus anterior: 10 repetitions and 3 sets. Infraspinatus: 10 repetitions 3 sets. Deep neck flexors: 30 seconds hold 3 sets.

Primary outcomes

  1. Craniovertebral Angle

    Time frame: From enrollment to the end of treatment at 6 weeks

    Universal Goniometer is utilized to measure the craniovertebral angle. An angle between 50 to 53 degrees is considered normal

  2. Reedco Posture Score

    Time frame: From enrollment to the end of treatment at 6 weeks

    Reedco Posture score is used to assess posture. The RPS includes personal information about the person being evaluated, along with a scoring system for various body parts. Each body part is assigned a score between 0 and 10, with 10 indicating good posture 5 indicating fair posture, and 0 indicating poor posture. The total score is calculated by adding up the scores for all the body parts. A perfect score would be 100, indicating excellent posture.

  3. Neck Disability Index

    Time frame: From enrollment to the end of treatment at 6 weeks

    Neck Disability Index is 10-item questionnaire regarding functional activities of the neck. Each item has 6 categories with 0 being the least score and 5 being the highest score. The sum of the selected categories in each item are calculated and scored out of a total possible score of 50. The NDI score is assessed as a percentage if the patient skips an item.

Study contacts

Contact information is provided by the study sponsor or research team.

Imran Amjad, Ph.D

CONTACT

[email protected]

+923324390125

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Effects of Klapp Method on Posture, Craniovertebral Angle and Disability in Upper Cross Syndrome Patients

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 27, 2026
Registry last updated
Feb 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.